North America Non-specific Endonucleases Market Size & Outlook
Related Markets
North America non-specific endonucleases market highlights
- The North America non-specific endonucleases market generated a revenue of USD 160.5 million in 2025.
- The market is expected to grow at a CAGR of 6% from 2026 to 2033.
- In terms of segment, recombinant non-specific endonucleases was the largest revenue generating product in 2025.
- Recombinant Non-Specific Endonucleases is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2026 to 2033.
North America data book summary
| Market revenue in 2025 | USD 160.5 million |
| Market revenue in 2033 | USD 254.4 million |
| Growth rate | 6% (CAGR from 2026 to 2033) |
| Largest segment | Recombinant non-specific endonucleases |
| Fastest growing segment | Recombinant Non-Specific Endonucleases |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Recombinant Non-Specific Endonucleases, Natural Source Enzymes, Engineered/Modified Variants |
Other key industry trends
- In terms of revenue, North America region accounted for 44.3% of the global non-specific endonucleases market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 150.7 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Non-specific Endonucleases Market Scope
Non-specific Endonucleases Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Promega Corporation | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| ArcticZymes Technologies | View profile | 11-50 | Tromsø, Troms, Norway, Europe | https://arcticzymes.com/ |
| RayBiotech | View profile | 101-250 | Norcross, Georgia, United States, North America | http://www.raybiotech.com/ |
| Transgene SA | View profile | 158 | 400 Boulevard Gonthier d’Andernach, Parc d’Innovation, Illkirch-Graffenstaden, France, 67400 | https://www.transgene.fr |
| ACROBiosystems | View profile | 251-500 | Newark, Delaware, United States, North America | https://www.acrobiosystems.com/ |
| Vazyme Biotech | View profile | 1001-5000 | Nanjing, Jiangsu, China, Asia | http://www.vazymebiotech.com/ |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | http://neb.com |
| Genscript Biotech Corp Class H | View profile | 6937 | No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, China, People's Republic of, 211100 | https://www.genscript.com |
| Bio-Techne Corp | View profile | 3050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | https://www.bio-techne.com |
| Kerry Logistics Network Ltd | View profile | 33100 | 55 Wing Kei Road, 16th Floor, Kerry Cargo Centre, New Territories, Kwai Chung, Hong Kong, Hong Kong, | https://www.kln.com |
| Takara Bio Inc | View profile | 1793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | http://www.takara-bio.co.jp |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
North America non-specific endonucleases market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-specific endonucleases market will help companies and investors design strategic landscapes.
Recombinant non-specific endonucleases was the largest segment with a revenue share of 63.36% in 2025. Horizon Databook has segmented the North America non-specific endonucleases market based on recombinant non-specific endonucleases, natural source enzymes, engineered/modified variants covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to North America non-specific endonucleases market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America non-specific endonucleases market databook
-
Our clientele includes a mix of non-specific endonucleases market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America non-specific endonucleases market , including forecasts for subscribers. This continent databook contains high-level insights into North America non-specific endonucleases market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
North America non-specific endonucleases market size, by country, 2021-2033 (US$M)
North America Non-specific Endonucleases Market Outlook Share, 2025 & 2033 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
